This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Epo-Med Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hiroyuki Kouji: Innovator in Peptide Technology
Introduction
Hiroyuki Kouji is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of peptide technology, particularly in the development of anti-erythropoietin receptor peptides. His innovative work has the potential to impact various medical applications.
Latest Patents
Hiroyuki Kouji holds a patent for an anti-erythropoietin receptor peptide. The patent describes a peptide with a specific structure that includes various amino acids and modifications. This peptide is designed to interact with the erythropoietin receptor, which plays a crucial role in regulating red blood cell production.
Career Highlights
Kouji is associated with Epo-Med Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential therapeutic applications, particularly in treating conditions related to erythropoiesis.
Collaborations
Hiroyuki Kouji collaborates with notable colleagues, including Yoshiko Yasuda and Akira Katoh. These partnerships enhance the research environment and contribute to the innovative projects at Epo-Med Inc.
Conclusion
Hiroyuki Kouji is a key figure in peptide technology, with a focus on anti-erythropoietin receptor peptides. His contributions to the field are noteworthy and hold promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile